Article

Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the…

International Journal of Nanomedicine · 2017 · Zhao MZ, Li HY, Ma Y, Gong H, Yang S, Fang Q, Hu ZY

Key facts

Title Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1)
First author Zhao MZ, Li HY, Ma Y, Gong H, Yang S, Fang Q, Hu ZY
Journal International Journal of Nanomedicine
Published Mar 1, 2017
DOI 10.2147/IJN.S129976
Devices mentioned BK110039, DEN000008, K022086
Product codes mentioned JCI, KIP, KIT, NDS, NJT, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature